In vitro evaluation of combination therapies against hepatitis B virus replication

Antiviral Research

Volumn 29, Issue 1, 1996, Pages 49-51

  Korba, Brent E ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Alpha interferon; Combination therapies; Hepatitis B virus

Indexed keywords

ANTIVIRUS AGENT; LAMIVUDINE; NUCLEOSIDE DERIVATIVE; PENCICLOVIR; RECOMBINANT ALPHA INTERFERON;

ANTIVIRAL ACTIVITY; CANCER CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG POTENTIATION; DRUG TARGETING; HEPATITIS B VIRUS; HEPATOBLASTOMA; HUMAN; HUMAN CELL; MODEL; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0029983056     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00915-9     Document Type: Conference Paper

References (5)

1. Deinstag, J.L., Perillo, R.P., Schiff, E.R., Bartholomew, M., Vicary, C. and Rubin, M. (1994) Double-blind, randomized, three-month, dose-ranging trial of lamivudine for chronic Hepatitis B. Hepatology 20, 412A.
2. Korba, B.E., Fernie, B., Tennant, B.C., Gangemi, D. and Gerin, J.L. (1993) A novel hybrid human interferon inhibits hepadnavirus replication in vitro and in vivo. Antiviral Res. 20 (suppl. 1), 163.
3. Korba, B.E. and Gerin, J.L. (1992) Use of a standardized cell culture system to evaluate nucleoside analogues for activity against Hepatitis B virus replication. Antiviral Res. 19, 55-70.
4. Korba, B.E. and Boyd, M.R. (1996) Pencictovir is an effective inhibitor of Hepatitis B virus replicator in vitro. Anti. Microb. Agents. Chemother. (in press).
5. Shaw, T., Amor, P., Civitico, G., Boyd, M. and Locarnini, S. (1994) In Vitro antiviral activity of Penciclovir, a novel purine nucleoside, against Duck Hepatitis B Virus. Antimicrob. Agents Chemother. 38, 719-723.